Hill J - Search Results

1

Switching from atorvastatin to simvastatin in patients at high cardiovascular risk: effects on low-density lipoprotein cholesterol.

Aronow HD, Hess G, Hill J, Kuznik A, Liu LZ. Aronow HD, et al. Among authors: hill j. Am J Ther. 2010 Mar-Apr;17(2):167-75. doi: 10.1097/MJT.0b013e3181b442b9. Am J Ther. 2010. PMID: 19770794

2

Therapeutic dose assessment of patient switching from atorvastatin to simvastatin.

Hess G, Sanders KN, Hill J, Liu LZ. Hess G, et al. Among authors: hill j. Am J Manag Care. 2007 Jun;13 Suppl 3:S80-5. Am J Manag Care. 2007. PMID: 17596116 Free article.

3

Effect of reimbursement changes on erythropoiesis-stimulating agent utilization and transfusions.

Hess G, Nordyke RJ, Hill J, Hulnick S. Hess G, et al. Among authors: hill j. Am J Hematol. 2010 Nov;85(11):838-43. doi: 10.1002/ajh.21837. Am J Hematol. 2010. PMID: 20976794 Free article.

4

Synchronization of administrations of chemotherapy and erythropoiesis-stimulating agents and frequency of associated healthcare visits.

Hill JW, Shreay S, McGarvey N, De AP, Hess GP, Corey-Lisle PK. Hill JW, et al. Support Care Cancer. 2013 Nov;21(11):2957-65. doi: 10.1007/s00520-013-1830-7. Epub 2013 Jun 12. Support Care Cancer. 2013. PMID: 23756616

5

Clinical burden of illness in patients with neuroendocrine tumors.

Hess GP, Chen CC, Liu Z, Yao JC, Phan AT, Hill JW. Hess GP, et al. Pancreas. 2012 Oct;41(7):1058-62. doi: 10.1097/MPA.0b013e318249d8f7. Pancreas. 2012. PMID: 22513292

6

Medication Utilization Patterns and Hypertension-Related Expenditures among Patients Who Were Switched from Fixed-Dose To Free-Combination Antihypertensive Therapy.

Hess G, Hill J, Lau H, Dastani H, Chaudhari P. Hess G, et al. Among authors: hill j. P T. 2008 Nov;33(11):652-66. P T. 2008. PMID: 19750061 Free PMC article.

7

The importance of clinical variables in comparative analyses using propensity-score matching: the case of ESA costs for the treatment of chemotherapy-induced anaemia.

Polsky D, Eremina D, Hess G, Hill J, Hulnick S, Roumm A, Whyte JL, Kallich J. Polsky D, et al. Among authors: hill j. Pharmacoeconomics. 2009;27(9):755-65. doi: 10.2165/11313860-000000000-00000. Pharmacoeconomics. 2009. PMID: 19757869

8

Hemoglobin decline in chemotherapy patients prior to and after policy changes affecting use of erythropoiesis-stimulating agents: 2006-2009.

Hill JW, Cong Z, Hess G, McGarvey N, Nordyke RJ. Hill JW, et al. J Int Med Res. 2012;40(4):1532-45. doi: 10.1177/147323001204000433. J Int Med Res. 2012. PMID: 22971506 Free article.

9

Comparative antibiotic failure rates in the treatment of community-acquired pneumonia: Results from a claims analysis.

Hess G, Hill JW, Raut MK, Fisher AC, Mody S, Schein JR, Chen CC. Hess G, et al. Adv Ther. 2010 Oct;27(10):743-55. doi: 10.1007/s12325-010-0062-1. Epub 2010 Aug 26. Adv Ther. 2010. PMID: 20799007 Free PMC article.

10

Utilization of darbepoetin alfa in relation to cancer patients' hemoglobin levels.

Hess G, Hill J, Clough J, Hulnick S, Nordyke RJ. Hess G, et al. Among authors: hill j. Curr Med Res Opin. 2008 Mar;24(3):815-9. doi: 10.1185/030079908X280383. Epub 2008 Feb 6. Curr Med Res Opin. 2008. PMID: 18257979

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,217 results

Search Page

Filters